Can anyone comment on how this may impact the IP landscape for CRISPR? [0]
[0] http://www.the-scientist.com/?articles.view/articleNo/42595/...
[0] http://www.the-scientist.com/?articles.view/articleNo/42595/...
New patents may have issued that are not so limited.
Further to this comment from [0]: "But with Cfp1, the stakes of that specific patent dispute go down. A lab or company could use Cfp1 without infringing on the CRISPR/Cas9 patent. "
[0] http://www.wired.com/2015/09/war-genome-editing-just-got-lot...